Serum Vitamin D Levels and Risk of Liver Cancer: A Systematic Review and Dose-Response Meta-Analysis of Cohort Studies

References

• El-Serag H. Hepatocellular carcinoma. N Engl J Med. 2011;365(12):1118–1127. doi:10.1056/NEJMra1001683
   PubMed Web of Science ®Google Scholar
• Ferlay J, Soerjomataram I, Ervik M, Dikshit R, Eser S, et al. Cancer incidence and mortality worldwide: IARC CancerBase.11. Lyon (France): International Agency for Research on Cancer; 2012.
   Google Scholar
• Dyal HK, Aguilar M, Bartos G, Holt EW, Bhuket T, Liu B, Cheung R, Wong RJ. Diabetes mellitus increases risk of hepatocellular carcinoma in chronic hepatitis C virus patients: a systematic review. Dig Dis Sci. 2016;61(2):636–645. doi:10.1007/s10620-015-3983-3
   PubMed Web of Science ®Google Scholar
• Hagström H, Tynelius P, Rasmussen F. High BMI in late adolescence predicts future severe liver disease and hepatocellular carcinoma: a national, population-based cohort study in 1.2 million men. Gut. 2018;67(8):1536–1542. doi:10.1136/gutjnl-2016-313622
   PubMed Web of Science ®Google Scholar
• Younes R, Bugianesi E. Should we undertake surveillance for HCC in patients with NAFLD? J Hepatol. 2018;68(2):326–334. doi:10.1016/j.jhep.2017.10.006
   PubMed Web of Science ®Google Scholar
• Suh B, Yun JM, Park S, Shin DW, Lee TH, Yang H-K, Ahn E, Lee H, Park JH, Cho B, et al. Prediction of future hepatocellular carcinoma incidence in moderate to heavy alcohol drinkers with the FIB-4 liver fibrosis index. Cancer. 2015;121(21):3818–3825. doi:10.1002/cncr.29577
   PubMed Web of Science ®Google Scholar
• Hepatology E. EASL–EORTC clinical practice guidelines: management of Hepatocellular Carcinoma. J Hepatol. 2012;56(4):908–943.
   PubMed Web of Science ®Google Scholar
• Sacco R, Gadaleta-Caldarola G, Galati G, Lombardi G, Mazza G, Cabibbo G. EASL HCC summit: liver cancer management. Future Oncol. 2014;10(7):1129–1132. doi:10.2217/fon.14.68
   PubMed Web of Science ®Google Scholar
• Finkelmeier F, Kronenberger B, Köberle V, Bojunga J, Zeuzem S, Trojan J, Piiper A, Waidmann O. Severe 25-hydroxyvitamin D deficiency identifies a poor prognosis in patients with hepatocellular carcinoma - a prospective cohort study . Aliment Pharmacol Ther. 2014;39(10):1204–1212. doi:10.1111/apt.12731
   PubMed Web of Science ®Google Scholar
• Manco M, Ciampalini P, Nobili V. Low levels of 25‐hydroxyvitamin D3 in children with biopsy‐proven nonalcoholic fatty liver disease. Hepatology. 2010;51(6):2229. doi:10.1002/hep.23724
   PubMed Web of Science ®Google Scholar
• Targher G, Bertolini L, Scala L, Cigolini M, Zenari L, Falezza G, Arcaro G. Associations between serum 25-hydroxyvitamin D3 concentrations and liver histology in patients with non-alcoholic fatty liver disease. Nutr Metabol Cardiovasc Dis. 2007;17(7):517–524. doi:10.1016/j.numecd.2006.04.002
   PubMed Web of Science ®Google Scholar
• Barchetta I, Angelico F, Del Ben M, Baroni MG, Pozzilli P, et al. Strong association between non alcoholic fatty liver disease (NAFLD) and low 25 (OH) vitamin D levels in an adult population with normal serum liver enzymes. BMC Med. 2011;9(1):85.
   PubMed Web of Science ®Google Scholar
• Petta S, Cammà C, Scazzone C, Tripodo C, Di Marco V, Bono A, Cabibi D, Licata G, Porcasi R, Marchesini G, et al. Low vitamin D serum level is related to severe fibrosis and low responsiveness to interferon‐based therapy in genotype 1 chronic hepatitis C. Hepatology. 2010;51(4):1158–1167. doi:10.1002/hep.23489
   PubMed Web of Science ®Google Scholar
• Vanoirbeek E, Krishnan A, Eelen G, Verlinden L, Bouillon R, Feldman D, Verstuyf A. The anti-cancer and anti-inflammatory actions of 1,25(OH)2D3. Best Pract Res Clin Endocrinol Metab. 2011;25(4):593–604. doi:10.1016/j.beem.2011.05.001
   PubMed Web of Science ®Google Scholar
• Stokes CS, Volmer DA, Grünhage F, Lammert F. Vitamin D in chronic liver disease. Liver Int. 2013;33(3):338–352. doi:10.1111/liv.12106
   PubMed Web of Science ®Google Scholar
• Plum LA, DeLuca H. Vitamin D, disease and therapeutic opportunities. Nat Rev Drug Discov. 2010;9(12):941–955. doi:10.1038/nrd3318
   PubMed Web of Science ®Google Scholar
• Kitson MT, Roberts S. D-livering the message: the importance of vitamin D status in chronic liver disease. J Hepatol. 2012;57(4):897–909. doi:10.1016/j.jhep.2012.04.033
   PubMed Web of Science ®Google Scholar
• Arteh J, Narra S, Nair S. sciences. Prevalence of vitamin D deficiency in chronic liver disease. Dig Dis Sci. 2010;55(9):2624–2628. doi:10.1007/s10620-009-1069-9
   PubMed Web of Science ®Google Scholar
• Li Q, Gao Y, Jia Z, Mishra L, Guo K, Li Z, Le X, Wei D, Huang S, Xie K, et al. Dysregulated Krüppel-like factor 4 and vitamin D receptor signaling contribute to progression of hepatocellular carcinoma. Gastroenterology. 2012;143(3):799–810. e2. doi:10.1053/j.gastro.2012.05.043
   PubMed Web of Science ®Google Scholar
• Chiang KC, Yeh CN, Chen MF, Chen T. Hepatocellular carcinoma and vitamin D: a review. J Gastroenterol Hepatol. 2011;26(11):1597–1603. doi:10.1111/j.1440-1746.2011.06892.x
   PubMed Web of Science ®Google Scholar
• Buonomo AR, Scotto R, Zappulo E, Nerilli M, Pinchera B, Perruolo G, Formisano P, Nappa S, Gentile I. Severe vitamin D deficiency increases mortality among patients with liver cirrhosis regardless of the presence of HCC. In Vivo. 2019;33(1):177–182. doi:10.21873/invivo.11456
   PubMed Web of Science ®Google Scholar
• Lai GY, Wang J-B, Weinstein SJ, Parisi D, Horst RL, McGlynn KA, Männistö S, Albanes D, Freedman ND. Association of 25-hydroxyvitamin D with liver cancer incidence and chronic liver disease mortality in finnish male smokers of the ATBC study. Cancer Epidemiol Biomarkers Prev. 2018;27(9):1075–1082. doi:10.1158/1055-9965.EPI-17-0877
   PubMed Web of Science ®Google Scholar
• Budhathoki S, Hidaka A, Yamaji T, Sawada N, Tanaka-Mizuno S, et al. Plasma 25-hydroxyvitamin D concentration and subsequent risk of total and site specific cancers in Japanese population: large case-cohort study within Japan Public Health Center-based Prospective Study cohort. BMJ (Online). 2018;360:k671.
   Google Scholar
• Fedirko V, Duarte-Salles T, Bamia C, Trichopoulou A, Aleksandrova K, Trichopoulos D, Trepo E, Tjønneland A, Olsen A, Overvad K, et al. Prediagnostic circulating vitamin D levels and risk of hepatocellular carcinoma in European populations: a nested case-control study. Hepatology (Baltimore, MD). 2014;60(4):1222–1230. doi:10.1002/hep.27079
   PubMed Web of Science ®Google Scholar
• Wang J-B, Abnet CC, Chen W, Dawsey SM, Fan J-H, Yin L-Y, Yin J, Major JM, Taylor PR, Qiao Y-L, et al. Association between serum 25(OH) vitamin D, incident liver cancer and chronic liver disease mortality in the Linxian Nutrition Intervention Trials: a nested case-control study. Br J Cancer. 2013;109(7):1997–2004. doi:10.1038/bjc.2013.546
   PubMed Web of Science ®Google Scholar
• Stroup DF, Berlin JA, Morton SC, Olkin I, Williamson GD, Rennie D, Moher D, Becker BJ, Sipe TA, Thacker SB, et al. Meta-analysis of observational studies in epidemiology: a proposal for reporting. JAMA. 2000;283(15):2008–2012. doi:10.1001/jama.283.15.2008
   PubMed Web of Science ®Google Scholar
• Stang A. Critical evaluation of the Newcastle-Ottawa scale for the assessment of the quality of nonrandomized studies in meta-analyses. Eur J Epidemiol. 2010;25(9):603–605. doi:10.1007/s10654-010-9491-z
   PubMed Web of Science ®Google Scholar
• Jackson D, White IR, Thompson SG. Extending DerSimonian and Laird's methodology to perform multivariate random effects meta-analyses. Stat Med. 2010;29(12):1282–1297. doi:10.1002/sim.3602
   PubMed Web of Science ®Google Scholar
• Harre FE, Jr Lee KL, Pollock BG. Regression models in clinical studies: determining relationships between predictors and response. J Natl Cancer Inst. 1988;80(15):1198–1202. doi:10.1093/jnci/80.15.1198
   PubMedGoogle Scholar
• Cancer Facts & Figures. 2019. American Cancer Society 2019. updated 2019/06/04. Available from: https://amp.cancer.org/research/cancer-facts-statistics/all-cancer-facts-figures/cancer-facts-figures-2019.html.
   Google Scholar
• Ogunwobi OO, Harricharran T, Huaman J, Galuza A, Odumuwagun O, Tan Y, Ma GX, Nguyen MT. Mechanisms of hepatocellular carcinoma progression. World J Gastroenterol. 2019;25(19):2279–2293. [updated May 21PMC6529884]. 2019/06/01:[2279-93]. doi:10.3748/wjg.v25.i19.2279
   PubMed Web of Science ®Google Scholar
• Forner A, Reig M, Bruix J. Hepatocellular carcinoma. Lancet (London, England). 2018;391(10127):1301–1314. doi:10.1016/S0140-6736(18)30010-2
   PubMed Web of Science ®Google Scholar
• Hartke J, Johnson M, Ghabril M. The diagnosis and treatment of hepatocellular carcinoma. Semin Diagn Pathol. 2017;34(2):153–159.
   Google Scholar
• Marengo A, Rosso C, Bugianesi E. Liver cancer: connections with obesity, fatty liver, and cirrhosis. Annu Rev Med. 2016;67:103–117. doi:10.1146/annurev-med-090514-013832
   PubMed Web of Science ®Google Scholar
• Gad MM, Al-Husseini MJ, Saad AM, Bazarbashi N, Al Obaid L. The risk of developing primary hepatocellular carcinoma following renal cell carcinoma; a seer-based study. Gastroenterology. 2019;156 (6):S-769. doi:10.1016/S0016-5085(19)38872-9
   PubMed Web of Science ®Google Scholar
• Chaker M, Saad AM, Al-Husseini MJ, Gad MM, Ruhban IA, Azmi AS. The risk of developing hepatocellular carcinoma following non-Hodgkin lymphoma. J Clin Oncol. 2018;36(15_suppl):e16141–e16141. doi:10.1200/JCO.2018.36.15_suppl.e16141
   Web of Science ®Google Scholar
• Mahendra A, Karishma BKC, Sharma T, Bansal N, Bansal R, et al. Vitamin D and gastrointestinal cancer. J Lab Phys. 2018;10(1):1. doi:10.4103/JLP.JLP_49_17
   PubMed Web of Science ®Google Scholar
• Khan S, Ali A, Khan S, Bakillah A, Damanhouri G, Khan A, Makki A, AlAnsari I, Banu N. Current therapies in alleviating liver disorders and cancers with a special focus on the potential of vitamin D. Nutr Metab (Lond)). 2018;15:13. doi:10.1186/s12986-018-0251-5
   PubMed Web of Science ®Google Scholar
• Budhathoki S, Hidaka A, Yamaji T, Sawada N, Tanaka-Mizuno S, et al. Plasma 25-hydroxyvitamin D concentration and subsequent risk of total and site specific cancers in Japanese population: large case-cohort study within Japan Public Health Center-based Prospective Study cohort. BMJ (Clinical Research ed). 2018;360:k671.
   PubMed Web of Science ®Google Scholar
• Louka ML, Fawzy AM, Naiem AM, Elseknedy MF, Abdelhalim AE, Abdelghany MA. Vitamin D and K signaling pathways in hepatocellular carcinoma. Gene. 2017;629:108–116. doi:10.1016/j.gene.2017.07.074
   PubMed Web of Science ®Google Scholar
• Chen E-Q, Shi Y, Tang H. New insight of vitamin D in chronic liver diseases. Hbpd Int. 2014;13(6):580–585. doi:10.1016/S1499-3872(14)60295-2
   Web of Science ®Google Scholar
• Kennedy L, Baker K, Hodges K, Graf A, Venter J, Hargrove L, Harris R, Harnish E, Meng F, Francis H, et al. Dysregulation of vitamin D3 synthesis leads to enhanced cholangiocarcinoma growth. Dig Liver Dis. 2013;45(4):316–322. doi:10.1016/j.dld.2012.12.012
   PubMedGoogle Scholar
• Mondul AM, Weinstein SJ, Layne TM, Albanes D. Vitamin D and cancer risk and mortality: state of the science, gaps, and challenges. Epidemiol Rev. 2017;39(1):28–48. doi:10.1093/epirev/mxx005
   PubMed Web of Science ®Google Scholar
• Colombo M, Sangiovanni A. Vitamin D deficiency and liver cancer: more than just an epidemiological association? Hepatology. 2014;60(4):1130–1132. doi:10.1002/hep.27178
   PubMed Web of Science ®Google Scholar
• Wu D-B, Wang M-L, Chen E-Q, Tang H. New insights into the role of vitamin D in hepatocellular carcinoma. Expert Rev Gastroenterol Hepatol. 2018;12(3):287–294. doi:10.1080/17474124.2018.1406307
   PubMed Web of Science ®Google Scholar
• Gomes TL, Fernandes RC, Vieira LL, Schincaglia RM, Mota JF, Nóbrega MS, Pichard C, Pimentel GD. Low vitamin D at ICU admission is associated with cancer, infections, acute respiratory insufficiency, and liver failure. Nutrition. 2019;60:235–240. doi:10.1016/j.nut.2018.10.018
   PubMed Web of Science ®Google Scholar
• Duran A, Hernandez ED, Reina-Campos M, Castilla EA, Subramaniam S, Raghunandan S, Roberts LR, Kisseleva T, Karin M, Diaz-Meco MT, et al. p62/SQSTM1 by binding to vitamin D receptor inhibits hepatic stellate cell activity, fibrosis, and liver cancer. Cancer Cell. 2016;30(4):595–609. doi:10.1016/j.ccell.2016.09.004
   PubMed Web of Science ®Google Scholar
• Berceanu D, Bucur D, Diaconu C. Type 2 diabetes and liver disease: a frequent and harmful connection. Archiv Balkan Med Union. 2016;51(4):506–511.
   Google Scholar
• Keane J, Elangovan H, Stokes R, Gunton J. Vitamin D and the liver—correlation or cause? Nutrients. 2018;10(4):496. doi:10.3390/nu10040496
   PubMed Web of Science ®Google Scholar
• Barooah P, Saikia S, Bharadwaj R, Sarmah P, Bhattacharyya M, Goswami B, Medhi S. Role of VDR, GC, and CYP2R1 polymorphisms in the development of hepatocellular carcinoma in hepatitis C virus-infected patients. Genet Test Mol Biomarkers. 2019;23(5):325–331. doi:10.1089/gtmb.2018.0170
   PubMed Web of Science ®Google Scholar
• Gotlieb N, Tachlytski I, Lapidot Y, Sultan M, Safran M, Ben-Ari Z. Hepatitis B virus downregulates vitamin D receptor levels in hepatoma cell lines, thereby preventing vitamin D-dependent inhibition of viral transcription and production. Mol Med. 2018;24(1):53. doi:10.1186/s10020-018-0055-0
   PubMed Web of Science ®Google Scholar
• Holick MF, Binkley NC, Bischoff-Ferrari HA, Gordon CM, Hanley DA, Heaney RP, Murad MH, Weaver CM. Evaluation, treatment, and prevention of vitamin D deficiency: an endocrine society clinical practice guideline. J Clin Endocrinol Metab. 2011;96(7):1911–1930. doi:10.1210/jc.2011-0385
   PubMed Web of Science ®Google Scholar
• Scaranti M, de Castro Júnior G, Hoff AO. Vitamin D and cancer: does it really matter? Curr Opin Oncol. 2016;28(3):205–209. doi:10.1097/CCO.0000000000000282
   PubMed Web of Science ®Google Scholar
• Chen J, Katz LH, Muñoz NM, Gu S, Shin J-H, Jogunoori WS, Lee M-H, Belkin MD, Kim S-B, White JC, et al. Vitamin D deficiency promotes liver tumor growth in transforming growth factor-β/Smad3-deficient mice through Wnt and toll-like receptor 7 pathway modulation. Sci Rep. 2016;6:30217. doi:10.1038/srep30217
   PubMed Web of Science ®Google Scholar